Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis

被引:64
作者
Anstee, Quentin M. [1 ]
Wright, Mark [2 ]
Goldin, Robert [3 ]
Thursz, Mark R. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Acad Dept Med, London W2 1PG, England
[2] Southampton Gen Hosp, Dept Hepatol, Southampton SO9 4XY, Hants, England
[3] Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London W2 1PG, England
关键词
Liver; Fibrosis; Thrombophilia; Factor V Leiden; Coagulation; FACTOR-V-LEIDEN; LIVER FIBROSIS PROGRESSION; PORTAL-VEIN THROMBOSIS; C VIRUS; NATURAL-HISTORY; RISK-FACTORS; CIRRHOSIS; INFECTION; HEPARIN; DETERMINANTS;
D O I
10.1016/j.cld.2008.09.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Observations that hepatic inflammation and cirrhosis are associated with the presence of thrombi within the hepatic microvasculature and fibrin-fibrinogen deposition have led to epidemiologic studies showing that carriage of the factor V Leiden mutation, protein C deficiency, and increased expression of factor VIII are associated with rapid progression to cirrhosis in a chronic hepatitis C virus. Additional data suggest that this process may extend more broadly to progression in many forms of chronic liver disease. This article discusses the evidence for a role for coagulation cascade activity in hepatic fibrogenesis and explores the proposed pathogenic mechanisms including the downstream events of thrombin activation. Interference with either the generation of thrombin or its downstream activity may reduce hepatic fibrosis. Also examined are the implications for future therapeutic intervention.
引用
收藏
页码:117 / +
页数:11
相关论文
共 45 条
[1]   A study of unfractionated and low molecular weight heparins in a model of cholestatic liver injury in the rat [J].
Abdel-Salam, OME ;
Baiuomy, AR ;
Ameen, A ;
Hassan, NS .
PHARMACOLOGICAL RESEARCH, 2005, 51 (01) :59-67
[2]   Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat [J].
Abe, Wataru ;
Ikejima, Kenichi ;
Lang, Tie ;
Okumura, Kyoko ;
Enomoto, Nobuyuki ;
Kitamura, Tsuneo ;
Takei, Yoshiyuki ;
Sato, Nobuhiro .
JOURNAL OF HEPATOLOGY, 2007, 46 (02) :286-294
[3]   Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies [J].
Anstee, Q. M. ;
Goldin, R. D. ;
Wright, M. ;
Martinelli, A. ;
Cox, R. ;
Thursz, M. R. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (08) :1336-1343
[4]   Thrombin signalling and protease-activated receptors [J].
Coughlin, SR .
NATURE, 2000, 407 (6801) :258-264
[5]   Thrombin interactions [J].
Di Cera, E .
CHEST, 2003, 124 (03) :11S-17S
[6]   A role for thrombin in liver fibrosis [J].
Duplantier, JG ;
Dubuisson, L ;
Senant, N ;
Freyburger, G ;
Laurendeau, I ;
Herbert, JM ;
Desmoulière, A ;
Rosenbaum, J .
GUT, 2004, 53 (11) :1682-1687
[7]   Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement:: a randomised, double-blind, non-inferiority trial [J].
Eriksson, Bengt I. ;
Dahl, Ola E. ;
Rosencher, Nadia ;
Kurth, Andreas A. ;
van Dijk, C. Niek ;
Frostick, Simon P. ;
Prins, Martin H. ;
Hettiarachchi, Rohan ;
Hantel, Stefan ;
Schnee, Janet ;
Bueller, Harry R. .
LANCET, 2007, 370 (9591) :949-956
[8]   Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients [J].
Fattovich, G ;
Giustina, G ;
Degos, F ;
Tremolada, F ;
Diodati, G ;
Almasio, P ;
Nevens, F ;
Solinas, A ;
Mura, D ;
Brouwer, JT ;
Thomas, H ;
Njapoum, C ;
Casarin, C ;
Bonetti, P ;
Fuschi, P ;
Basho, J ;
Tocco, A ;
Bhalla, A ;
Galassini, R ;
Noventa, F ;
Schalm, SW ;
Realdi, G .
GASTROENTEROLOGY, 1997, 112 (02) :463-472
[9]   PAR1 antagonism protects against experimental liver fibrosis.: Role of proteinase receptors in stellate cell activation [J].
Fiorucci, S ;
Antonelli, E ;
Distrutti, E ;
Severino, B ;
Fiorentina, R ;
Baldoni, M ;
Caliendo, G ;
Santagada, V ;
Morelli, A ;
Cirino, G .
HEPATOLOGY, 2004, 39 (02) :365-375
[10]   Liver fibrosis - from bench to bedside [J].
Friedman, SL .
JOURNAL OF HEPATOLOGY, 2003, 38 :S38-S53